BioCatalyst

Volrustomig, Bevacizumab, Lenvatinib, Rilvegostomig — catalyst calendar

1 verified catalyst event(s) referencing Volrustomig, Bevacizumab, Lenvatinib, Rilvegostomig, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-27
in 4mo
ESTIMATED
 READOUT
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticance
Phase 2 · Hepatocellular Carcinoma, Biliary Tract Cancer
 AZN ASTRAZENECA PLC Volrustomig, Bevacizumab, Lenvatinib, Ri ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.